scispace - formally typeset
N

Nakissa Sadrieh

Researcher at Center for Drug Evaluation and Research

Publications -  39
Citations -  2529

Nakissa Sadrieh is an academic researcher from Center for Drug Evaluation and Research. The author has contributed to research in topics: Nephrotoxicity & Prussian blue. The author has an hindex of 23, co-authored 36 publications receiving 2280 citations. Previous affiliations of Nakissa Sadrieh include Food and Drug Administration.

Papers
More filters
Journal ArticleDOI

Minireview: Nanoparticles and the Immune System

TL;DR: In this paper, a review of observations on nanoparticle-mediated immunostimulation and immunosuppression, focusing on possible theories regarding how manipulation of particle physicochemical properties can influence their interaction with immune cells to attain desirable immunomodulation and avoid undesirable immunotoxicity.
Journal ArticleDOI

Research strategies for safety evaluation of nanomaterials, part VII: evaluating consumer exposure to nanoscale materials.

TL;DR: This paper seeks to review a limited subset of products that contain nanoscale materials, assess the available data for evaluating the consumer exposures and potential hazards associated with these products, and discuss the capacity of U.S. regulatory agencies to address the potential risks associated withThese products.
Journal ArticleDOI

Comparing methods for detecting and characterizing metal oxide nanoparticles in unmodified commercial sunscreens.

TL;DR: It was determined that several of the commercial sunscreens contained distinct nanoparticles, and no one method was able to completely characterize nanoparticles in the unmodified products but the viable methods provided complementary information regarding the nanoparticles and how they were interacting with the sunscreen matrix.
Journal ArticleDOI

Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs

TL;DR: The importance of long-term biodistribution and mass balance studies to understand the nanoparticle accumulation profile which may help to assess the safety and efficacy of the nanomaterial containing drug products is underlined.